Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Necrosis01:16

Necrosis

4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Overview of Cell Death01:30

Overview of Cell Death

7.3K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.3K
The Electron Transport Chain01:30

The Electron Transport Chain

16.6K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.6K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

3.3K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impacts of In Situ Wheat Straw Incorporation Methods on Cadmium Behavior in Soil-Rice Systems.

Foods (Basel, Switzerland)·2026
Same author

A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma.

MedComm·2026
Same author

Unraveling the co-evolution of lipidome and flavorome during the light-frying of grass carp cubes: Interactions between lipid oxidation and Maillard reaction.

Food chemistry·2026
Same author

Straw mulching combined with alternate wetting and drying reduces methane emissions in paddy fields: associations with carbon availability and methanogenic archaeal community shifts.

Journal of environmental management·2026
Same author

Effects of cerebral infarction on cognitive and speech performance.

BMC medical informatics and decision making·2026
Same author

Long-Term Lesion Progression After Left Main Distal Bifurcation Stenting: Insights From Bifurcation Angle Variation Throughout the Cardiac Cycle.

Reviews in cardiovascular medicine·2026

Related Experiment Video

Updated: Jun 27, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

956

Important molecular mechanisms in ferroptosis.

Lunmeng Lai1, Menglei Tan1, Mingming Hu1

  • 1Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Suzhou Medical College of Soochow University, Soochow University, Suzhou, China.

Molecular and Cellular Biochemistry
|April 26, 2024
PubMed
Summary

Ferroptosis, a distinct cell death form driven by iron and lipid oxidation, is increasingly linked to signaling pathways like Nrf2, P53, and YAP/TAZ. Targeting these pathways offers new therapeutic strategies for diseases such as cancer.

Keywords:
Cell signaling pathwayFerroptosisNuclear factor-erythroid 2-related factor 2P53

More Related Videos

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

189
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

897

Related Experiment Videos

Last Updated: Jun 27, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

956
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

189
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

897

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Medicine

Background:

  • Ferroptosis is a regulated cell death characterized by iron-dependent lipid peroxidation.
  • Distinct from apoptosis and necroptosis, ferroptosis research has rapidly expanded since its 2012 characterization.
  • While lipid metabolism and mitochondria are key, signaling pathways and proteins (Nrf2, P53, YAP/TAZ) are now recognized as crucial regulators.

Purpose of the Study:

  • To review critical signaling pathways involved in ferroptosis.
  • To discuss drugs targeting these pathways for ferroptosis-related diseases.
  • To systematically address established and potential therapeutic targets for ferroptosis.

Main Methods:

  • Literature review of studies on ferroptosis signaling pathways.
  • Analysis of therapeutic agents targeting ferroptosis-related signaling.
  • Systematic evaluation of therapeutic targets for ferroptosis-associated conditions.

Main Results:

  • Signaling pathways including Nrf2, P53, and YAP/TAZ play significant roles in ferroptosis.
  • Various drugs targeting these pathways have been developed and utilized.
  • Established and potential therapeutic targets for ferroptosis-related diseases are identified.

Conclusions:

  • Signaling pathways are critical regulators of ferroptosis.
  • Targeting these pathways with specific drugs offers therapeutic potential for ferroptosis-related diseases.
  • Further research into therapeutic targets for conditions like cancer and ischemic heart disease is warranted.